Butterfly Network Stock Slides As Licensing Story Expands

Butterfly Network Inc. stocks have been trading up by 7.91 percent following strong positive sentiment around its imaging technology advancements.

Live Update At 11:32:22 EDT: On Tuesday, June 23, 2026 Butterfly Network Inc. stock [NYSE: BFLY] is trending up by 7.91%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

Butterfly Network, trading under ticker BFLY, is acting like a classic high-volatility story stock. Over the past few weeks, BFLY has run from roughly $4.40s at the start of June to the high $8s on 2026/06/18, then pulled back into the low-to-mid $7s. That’s a near-double off the lows followed by a hard check of recent gains. Traders are clearly treating BFLY as an event-driven name.

On 2026/06/23, BFLY opened at $6.82 and pushed to an intraday high just under $7.90, closing at $7.84. The intraday five‑minute chart shows a steady grind higher from the low $7s, with dips getting bought and the tape stair‑stepping up. That’s classic active-trader territory: high range, clean intraday trend, and plenty of liquidity.

More Breaking News

• CDT Equity Slides Onto Nasdaq’s Watchlist After Late 10-Q
• Redwire (RDW) Stock Whipsaws After Jefferies Downgrade
• VTAK Stock Draws Traders As Flyte Bets On AI Aviation
• RXT Slides As Insider Form 144 Filings Rattle Traders

Fundamentally, Butterfly Network is still early in its profit story. The latest quarter shows about $26.5M in revenue on a trailing annual base of roughly $97.6M, but margins are deeply negative, with EBIT margin around -72% and profit margin near -74%. Cash burn is real: operating cash flow was about -$13.9M for the quarter, but BFLY ended with roughly $142M in cash and a current ratio of 4.0, plus low debt. In plain English, Butterfly Network is losing money but has runway to keep building its Ultrasound‑on‑Chip and AI platform while traders surf the volatility.

Why Traders Are Watching BFLY Right Now

The main reason BFLY is on so many screens is the Midjourney Medical partnership. Midjourney has publicly launched a full‑body tomographic ultrasound scanner that embeds Butterfly Network’s Ultrasound‑on‑Chip modules under an existing co‑development and licensing deal. That agreement could deliver up to $74M over five years, with the possibility of more if the platform gains traction. For a company doing under $100M in annual revenue, that’s not pocket change.

Butterfly Network confirmed that each Midjourney system uses 40 of its Ultrasound‑on‑Chip modules. Future generations are expected to use substantially more. That kind of content expansion is exactly what traders look for in hardware‑plus‑licensing stories. If unit volumes grow and module counts per system rise, BFLY’s revenue per installation and operating leverage both climb. It shifts Butterfly Network from being only a handheld device maker into a critical component supplier across a broader imaging ecosystem.

At the same time, the stock is reminding traders that upside narratives do not erase risk. Butterfly Network shares recently plunged 18.8% in a single session to $7.22, showing how fast sentiment can flip. That type of one‑day drawdown usually means heavy funds rotating out, stop losses getting hit, or the market re‑rating risk.

Layer on the Form 4 filing showing a change in beneficial ownership by an insider or major holder, and it’s clear the tape is not sleepy. Capital is actively moving around Butterfly Network, and BFLY is trading like a high‑beta, headline‑driven small cap. With the TD Cowen Emerging Growth Call on 2026/06/18, traders will be listening closely for more color on the Midjourney pipeline, module content per system, and broader licensing plans around Ultrasound‑on‑Chip and AI software. Any perceived upgrade or downgrade to that story can move BFLY fast.

Conclusion

Butterfly Network sits at the intersection of two powerful themes: democratizing medical imaging and monetizing enabling technology through licensing. BFLY already plays a leading role in handheld ultrasound and point‑of‑care imaging, pairing hardware with AI to push scans closer to the bedside and even into lower‑resource settings. The Midjourney Medical full‑body scanner puts that strategy on a bigger stage, with 40 Butterfly modules per system today and potential for more in future versions. A pathway to up to $74M in licensing revenue over five years gives traders a concrete number to plug into their models.

But the chart is a loud reminder that story stocks punish anyone who gets complacent. The 18.8% single‑day drop to $7.22 shows how quickly Butterfly Network can air‑pocket when sentiment turns. Deep negative margins, ongoing cash burn, and a premium price‑to‑sales multiple mean BFLY is still a speculation, not a steady compounder. Trading this name requires tight risk control and respect for gap risk around news and events like the TD Cowen call.

For active traders studying BFLY, the setup is simple: big upside if the Ultrasound‑on‑Chip licensing flywheel spins, big downside if execution or adoption disappoints. As Tim Sykes likes to say, “The market doesn’t care about your opinion, only your discipline.” As millionaire penny stock trader and teacher Tim Sykes, says, “Cut losses quickly, let profits ride, and don’t overtrade.”. Butterfly Network is giving disciplined traders opportunity on both sides of the tape — as long as they manage risk first and treat every move as an educational, research‑driven trade, not a guarantee.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

• Penny Stocks Trading Guide
• Best Penny Stocks Under $1 to Buy Today
• Top 8 Penny Stocks to Watch on Robinhood

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks